advert
Angel News

Back to Homepage

12th April 2024 - 0 comments

Development Bank invests in global healthcare AI tech

Bridgend-based AI technology firm Clinithink is helping to improve patient care, relieve workloads for stretched clinicians and deliver significant savings to the NHS with investment from the Development Bank of Wales.

22nd March 2024 - 0 comments

Cell tech company CryoLogyx raises £500k from angel investors

CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, has closed an oversubscribed seed funding round. The £500,000 investment came from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), which includes previous investors Oxford Technology Management. 

15th March 2024 - 0 comments

Jetbio commercialises its groundbreaking 3D bioprinting

Newcastle University spinout Jetbio is introducing 3D bioprinting products in the global multi-billion-dollar 3D bioprinting market for drug discovery, tissue engineering and regenerative medicine.

8th March 2024 - 0 comments

Newcells Biotech raises £2.35m for lab models that help avoid animal testing

Newcells Biotech, whose laboratory models are used in drug development and reduce reliance on animal testing, has raised a further £2.35m to boost its growth and help establish itself as a global leader in its field. 

The Newcastle-based company has secured funding from existing investors including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds and Northstar Ventures. It brings the total raised by the company to date to over £12m.

8th March 2024 - 0 comments

The Investors Club backs Resalis Therapeutics

ITALY: The Investors Club has invested in the 10 million euro round of Resalis Therapeutics.  The club gave a special thanks to its champion Guido Bonazzola, who contributed in a fundamental way to the realization of this initiative. Guido's active participation and commitment helped make this significant investment possible.

1st March 2024 - 0 comments

London prosthetics startup Koalaa rasies $1.2 million

London startup, Koalaa, whose world-first soft prosthetic arms are aiding independence for individuals with limb differences around the world, has closed a funding round of $1.2 million led by British Design Fund.

23rd February 2024 - 0 comments

 Mercia leads £7 million financing for MIP Discovery

MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and production of cell and gene therapies, has closed a £7m (~$9m USD) Series A financing round led by Mercia Ventures. Existing investor Calculus Capital also participated in the round, along with Angel investors.

23rd February 2024 - 0 comments

Angel-backed water tech InferSens launches legionella solution

Cambridge-based Infersens has launched Cortense®, its first commercially available solution to transform Legionella risk management and dramatically cut water waste.

16th February 2024 - 0 comments

 London prosthetics startup Koalaa raises $1.2 million

London startup, Koalaa, whose world-first soft prosthetic arms are aiding independence for individuals with limb differences around the world, has closed a funding round of $1.2 million (£925,000).  The round was initiated by existing investor British Design Fund and includes £200,000 secured from the Imperial College Enterprise Fund II (ICEF), which invests in startup companies that have a strong connection to the University.  Business angels also took part in the round. The funds raised in this round, which started in July 2022, are being used to expand Koalaa’s business internationally.

9th February 2024 - 0 comments

Spin-out raises £1.4m for lung test to aid early diagnosis of asthma

PulmoBioMed  - a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions - has raised £1.4m to help commercialise its technology and target the US market.  The investment round was led by the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, and included Northumbria University, SFC Capital and private investors in the USA, EU and UK. The company has also secured a £700,000 grant from Innovate UK to help it demonstrate the benefits of its technology.

2nd February 2024 - 0 comments

ALKemist Bio announces a €6.9M investment from IAG

Newly launched TCR company ALKemist Bio has closed a €6.9 million funding round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors.

12th January 2024 - 0 comments

DSW Ventures and NGBio invest £1.4m in Mesenbio

Mesenbio, a University of York spin-out that is developing a novel treatment for arthritis created from engineered human stem cells, has raised £1.4m in an investment round co-led by DSW Ventures and NG Bio alongside grant funding from Innovate UK.

The treatment will initially target rheumatoid arthritis, an autoimmune disease that impacts nearly half a million adults and children in the UK alone, causing debilitating joint pain and inflammation of the hands, knees, elbows, ankles, and wrists.

Items of 494NEXT

Back to Homepage